Low-value prostate cancer screening among older men within the Veterans Health Administration

Journal of the American Geriatrics Society Sep 19, 2019

Radomski TR, Huang Y, Park SY, et al. - Using retrospective cohort design and Veterans Health Administration (VA) data (2014 to 2015) from 214,480 male veterans, aged 75 years or older, researchers quantified the prevalence as well as the variation of low-value prostate-specific antigen (PSA) screening across the VA, which has instituted programs to attenuate low-value care. In men aged 75 years or older without a history of prostate cancer, they defined PSA screening as low value, by established definitions in Medicare. They computed screening rates overall and by VA Medical Center (VAMC), adjusting for patient and VAMC-level factors. Findings revealed the receipt of low-value PSA screening by more than one in six older veterans studied in this national cohort, with greater than 10-fold variation across VAMCs. Those with the greatest mortality risk exhibited high rates of screening.
Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen